Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis
NeuroRehabilitation · 28.06.2024 · 54 (4) · 663-675
DOI: 10.3233/nre-240038 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift NeuroRehabilitation, erschienen am 28.06.2024. Verfasst von Aránzazu Vázquez-Doce und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Hospital Universitario de La Princesa, Madrid, Spain. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Multiple Sclerosis, Neuromuscular Agents, Paraparesis, Spastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Multiple sclerosis (MS) is the most common neurologic disease in young adults. Spasticity is one of its most disabling symptoms, with botulinum toxin A type A (BoNT-A) being one of the treatments of choice for this symptom. OBJECTIVE: We assessed the response to abobotulinumtoxinA in improving walking ability and fatigue in patients with spastic paraparesis caused by MS. METHODS: We performed a real-world, multicenter, prospective, open-label low-intervention trial in 84 patients with MS and spastic paraparesis of the lower limbs infiltrated with abobotulinumtoxinA (LINITOX study). The response of spasticity, walking ability and fatigue is analyzed in 4 cycles of ultrasound-guided injection in the lower limbs. RESULTS: The patients improved their walking ability by an average of 11.34% meters measured with 6-Minute Walk Test (6MWT), and decreased the percentage of fatigue by 6.86% (4.66 percentage points less), in the 12-Item Multiple Sclerosis Walking Scale (MSWS-12) 4 weeks after abobotulinumtoxinA injection, both values are statistically significant. This improvement seems to persist over time, throughout the cycles. CONCLUSION: We found improved walking ability and less fatigue in patients with MS-related spastic paresis of the lower limbs after injection of abobotulinumtoxinA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, Hospital Universitario de La Princesa, Madrid, Spain.
- Sport Traumatology, Hospital San Rafael, Madrid, Spain.
- Laboratori Nazionali di Frascati INFN, Frascati, Italy.
- Department of Physical Medicine and Rehabilitation, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Zitieren
APA
Vázquez-Doce, A., Delgado, L. G., Arriaza Gómez, M. J., Spottorno Rubio, M. P., Lallana, V. M., Muñoz, B. D. R., Bosch-Martín, M. A., Doce, O. V., García, P. O., & Juan, N. T. (2024). Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis. NeuroRehabilitation, 54(4), 663-675. https://doi.org/10.3233/nre-240038
Vancouver
Vázquez-Doce A, Delgado LG, Arriaza Gómez MJ, Spottorno Rubio MP, Lallana VM, Muñoz BDR, et al. Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis. NeuroRehabilitation. 2024;54(4):663-675. doi:10.3233/nre-240038
BibTeX
@article{VzquezDoce2024,
author = {Vázquez-Doce, Aránzazu and Delgado, Laura García and Arriaza Gómez, María José and Spottorno Rubio, María Pía and Lallana, Virginia Meca and Muñoz, Beatriz Del Rio and Bosch-Martín, María Asunción and Doce, Otón Vázquez and García, Paula Ortega and Juan, Noemí Tapiador},
title = {Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis},
journal = {NeuroRehabilitation},
year = {2024},
volume = {54},
number = {4},
pages = {663--675},
doi = {10.3233/nre-240038}
}
EUVIMED